Insider · CIK 0001533228

Garland J. Scott

Reports to the SEC for 10 companies · BURLINGAME, CA

sec.gov

Transactions

Companies

Filings

CIK

0001533228

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−13K sh	—	—	46,372
2026-10-01	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+13K sh	$15.47	+$201K	13,000
2026-10-01	ELVNEnliven Therapeutics, Inc.S Sale	Director	SSale	−13K sh	$46.67	−$607K	0
2026-06-18	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+29.5K sh	—	—	29,500
2026-06-03	LBRXLB PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−32.3K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Restricted Stock Unit (RSU)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−28.7K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−37.5K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2026-04-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−48.1K sh	—	—	0
2026-02-12	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,427 sh	—	—	1,427
2026-01-20	ALXOALX ONCOLOGY HOLDINGS INC · Stock option (right to buy)A Award	Director	AAward	+40.4K sh	—	—	40,400
2026-01-07	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+59.4K sh	—	—	59,372
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+48.1K sh	—	—	48,072
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+28.7K sh	—	—	28,700
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−37.5K sh	—	—	0
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+37.5K sh	—	—	37,500
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−32.3K sh	—	—	0
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+32.3K sh	—	—	32,335
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−48.1K sh	—	—	0
2025-11-06	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)D Disposition to Issuer	Director	DDisposition to Issuer	−28.7K sh	—	—	0
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	Director	AAward	+22.4K sh	—	—	22,449
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.9K sh	—	—	0
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	Director	AAward	+17.9K sh	—	—	17,929
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,585 sh	—	—	0
2025-09-10	LBRXLB PHARMACEUTICALS INC · Employee Stock Option (Right to Buy)A Award	Director	AAward	+3,585 sh	—	—	3,585
2025-06-11	OLMAOlema Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+24.2K sh	—	—	24,150
2025-06-02	DAWNDay One Biopharmaceuticals, Inc. · Deferred Restricted Stock Unit (RSU)A Award	Director	AAward	+15K sh	—	—	15,000
2025-06-02	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+22.5K sh	—	—	22,500
2025-01-21	ALXOALX ONCOLOGY HOLDINGS INC · Common StockA Award	Director	AAward	+40.4K sh	—	—	40,400
2024-06-14	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000
2024-06-13	ALXOALX ONCOLOGY HOLDINGS INC · Stock Option (right to buy)A Award	Director	AAward	+20.2K sh	—	—	20,200
2024-05-23	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award	Director	AAward	+32.3K sh	—	—	32,335
2023-10-16	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,347
2023-10-16	OLMAOlema Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.5K sh	—	—	21,520
2023-06-22	DAWNDay One Biopharmaceuticals, Inc. · Director Stock Option (Right to buy Common Stock)A Award	Director	AAward	+37.5K sh	—	—	37,500
2023-06-20	ALXOALX ONCOLOGY HOLDINGS INC · Stock Option (right to buy)A Award	Director	AAward	+10.1K sh	—	—	10,100
2022-11-28	ALXOALX ONCOLOGY HOLDINGS INC · Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,009
2022-06-21	DAWNDay One Biopharmaceuticals, Inc. · Director Stock Option (Right to buy Common Stock)A Award	Director	AAward	+28.7K sh	—	—	28,700
2022-06-01	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-08-16	DAWNDay One Biopharmaceuticals, Inc. · Stock Option (Right to buy Common Stock)A Award	Director	AAward	+48.1K sh	—	—	48,072
2021-06-11	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-07-31	Calithera Biosciences, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-07-02	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−200K sh	$5.21	−$1.04M	0
2020-07-02	PORTOLA PHARMACEUTICALS INCD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−24.5K sh	$18.00	−$442K	0
2020-07-02	PORTOLA PHARMACEUTICALS INCD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1,173 sh	$18.00	−$21.1K	0
2020-07-02	PORTOLA PHARMACEUTICALS INCPerformance Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−100K sh	—	—	0
2020-07-02	PORTOLA PHARMACEUTICALS INCPerformance Stock UnitsD Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−50K sh	—	—	0
2020-07-02	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−100K sh	—	—	0

Recent filings

Accepted (ET)
Oct 5 16:574
Garland J. Scott0001533228-26-000009
SEC(opens sec.gov)
Jun 234
Garland J. Scott0001533228-26-000008
SEC(opens sec.gov)
Jun 54
Garland J. Scott0001533228-26-000006
SEC(opens sec.gov)
Apr 234
Garland J. Scott0001533228-26-000004
SEC(opens sec.gov)
Feb 174
Garland J. Scott0001533228-26-000003
SEC(opens sec.gov)
Jan 214
Garland J. Scott0001193125-26-018037
SEC(opens sec.gov)
Jan 94
Garland J. Scott0001533228-26-000002
SEC(opens sec.gov)
Nov 74
Garland J. Scott0001533228-25-000004
SEC(opens sec.gov)

Companies

Address

C/O ENLIVEN THERAPEUTICS, INC. 205 PARK ROAD

BURLINGAME, CA, 94010